TREU JESSE I 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 11, 2020

Form 4

Period: 2020-06-09

Director10% Owner

Transactions

Award
Stock Option (right to buy)
2020-06-09+2,311→ 2,311 total
Exercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (2,311 underlying)
Award
Stock Option (right to buy)
2020-06-09+2,465→ 2,465 total
Exercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (2,465 underlying)
Award
Stock Option (right to buy)
2020-06-09+26,503→ 26,503 total
Exercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (26,503 underlying)

Footnotes (3)

[F1]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date.
[F2]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date.
[F3]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date.

Documents

1 file